These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 24332600)

  • 1. "Fere libenter homines id quod volunt credunt": apprehension for the stroke reduction in the KYOTO HEART Study on the basis of meta-regression from the evidence.
    Takagi H; Umemoto T;
    Int J Cardiol; 2014 Jan; 170(3):258-60. PubMed ID: 24332600
    [No Abstract]   [Full Text] [Related]  

  • 2. Primary and secondary prevention of stroke by antihypertensive drug treatment.
    Wang JG; Li Y
    Expert Rev Neurother; 2004 Nov; 4(6):1023-31. PubMed ID: 15853529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood pressure reduction and cardiovascular prevention: meta-regression using ordered categorical (ordinal) event data.
    Geeganage CM; Tracy M; Bath MW; Bath PM
    J Hypertens; 2010 Oct; 28(10):1995-9. PubMed ID: 20577120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of heart rate on central hemodynamics and stroke: a meta-analysis of β-blocker trials.
    Ding FH; Li Y; Li LH; Wang JG
    Am J Hypertens; 2013 Jan; 26(1):118-25. PubMed ID: 23382335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary prevention of stroke: PROGRESS and the evidence for blood pressure reduction.
    Jackson G
    Int J Clin Pract; 2001 Dec; 55(10):655. PubMed ID: 11777285
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evidence of the therapeutic effect of antihypertensive therapy: meta-analysis and meta-regression of randomized and controlled trials].
    Jovell AJ; Cappelleri JC
    Med Clin (Barc); 2000; 114 Suppl 2():28-33. PubMed ID: 10916803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood pressure lowering and stroke events in type 2 diabetes: A network meta-analysis of randomized controlled trials.
    Xie XX; Liu P; Wan FY; Lin SG; Zhong WL; Yuan ZK; Zou JJ; Liu LB
    Int J Cardiol; 2016 Apr; 208():141-6. PubMed ID: 26855067
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cerebrovascular disease: Impact of INDANA meta-analysis and PROGRESS trial].
    Matsumoto M
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():605-11. PubMed ID: 15179938
    [No Abstract]   [Full Text] [Related]  

  • 9. [Acute blood pressure decrease in stroke has no advantage].
    Füessl HS
    MMW Fortschr Med; 2014 Jan; 156(1):33. PubMed ID: 24930304
    [No Abstract]   [Full Text] [Related]  

  • 10. Aggressive lowering of blood pressure.
    Kannel WB; Vasan RS
    Lancet; 2006 Aug; 368(9536):627-8. PubMed ID: 16920451
    [No Abstract]   [Full Text] [Related]  

  • 11. [Preventing stroke. Which antihypertensive drugs can do it better?].
    Böhm S
    MMW Fortschr Med; 2002 Jul; 144(29-30):14-5. PubMed ID: 12219605
    [No Abstract]   [Full Text] [Related]  

  • 12. Blood pressure-lowering treatment for primary and secondary prevention of different types of stroke.
    Arima H
    Expert Rev Cardiovasc Ther; 2009 Jun; 7(6):627-36. PubMed ID: 19505278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertension: treating the patient as well as the blood pressure.
    Jackson G
    Int J Clin Pract; 2003 Jun; 57(5):357. PubMed ID: 12846335
    [No Abstract]   [Full Text] [Related]  

  • 14. [Calcium antagonists in therapy of hypertension. Effective in preventing stroke?].
    Rafflenbeul W
    MMW Fortschr Med; 2001 Aug; 143(31-32):33-4. PubMed ID: 11556185
    [No Abstract]   [Full Text] [Related]  

  • 15. Angiotensin receptor blockers in hypertension. New insights from Japan.
    Verdecchia P; Angeli F; Mazzotta G; Ambrosio G; Reboldi G
    Hypertens Res; 2010 May; 33(5):394-7. PubMed ID: 20150909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of chronic hypertension for the prevention of stroke.
    Naidech AM; Weisberg LA
    South Med J; 2003 Apr; 96(4):359-62. PubMed ID: 12916554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sub-group analyses: to do or not to do?
    Gueyffier F
    J Hypertens; 2004 Mar; 22(3):467-9. PubMed ID: 15076150
    [No Abstract]   [Full Text] [Related]  

  • 18. Blood pressure reduction and cardiovascular prevention: an update including the 2003-2004 secondary prevention trials.
    Staessen JA; Li Y; Thijs L; Wang JG
    Hypertens Res; 2005 May; 28(5):385-407. PubMed ID: 16156503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of hypertension in patients 80 years and older: the lower the better? A meta-analysis of randomized controlled trials.
    Bejan-Angoulvant T; Saadatian-Elahi M; Wright JM; Schron EB; Lindholm LH; Fagard R; Staessen JA; Gueyffier F
    J Hypertens; 2010 Jul; 28(7):1366-72. PubMed ID: 20574244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A meta-analysis of randomized trials of telmisartan vs. valsartan therapy for blood pressure reduction.
    Takagi H; Niwa M; Mizuno Y; Goto SN; Umemoto T;
    Hypertens Res; 2013 Jul; 36(7):627-33. PubMed ID: 23344134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.